Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray plus propofol for painless gastrointestinal endoscopy
ChiCTR2500109904Phase 4Not yet recruiting
- Sponsor
- Xuzhou Mining Group General Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in gastrointestinal conditions (2 arms), sponsored by Xuzhou Mining Group General Hospital. Primary endpoint: Respiratory depression. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2500109904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109904.